Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01669 |
| Species: | Homo sapiens |
| Position : | chr7:100772345-100778921 |
| Year: | 2020 |
| Title: | ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | endometriosis |
| PMID: | 33176148 |
| MONDO: | MONDO:0005302 |
| Tissue: | Endometrium |
| Tissue Ontology ID: | UBERON:0001295 |
| Cell Source: | 12Z human endometriosis epithelial cells |
| CVCL ID: | CVCL_UG04 |
| Cell Type: | endometriotic epithelial cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, ATAC-seq, CUT&RUN |
| Low Throughput Method: | siRNA Knockdown, RT-RT-qPCR, Western blot |
| Target gene : | SERPINE1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|